Intractable Pain
1
Pipeline Programs
2
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Flowonix MedicalNJ - Hackettstown
2 programsInfusion PumpN/A1 trial
Prometra Programmable PumpN/A1 trial
Active Trials
NCT00866164Approved For Marketing
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
Sorrento TherapeuticsIntrathecal Resiniferatoxin
Flowonix MedicalInfusion Pump
Clinical Trials (3)
Total enrollment: 155 patients across 3 trials
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
Start: Aug 2009Est. completion: Feb 202745 patients
Phase 1Recruiting
Prometra's Utilization in Mitigating Pain II
N/AApproved For Marketing
Prometra's Utilization in Mitigating Pain (PUMP)
Start: Jan 2007Est. completion: Mar 2011110 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 155 patients
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.